Cargando…

Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of Brazil

BACKGROUND: Knowledge of HBV genotype is very important for clinical treatment. Studies have suggested possible pathogenic and therapeutic differences among HBV genotypes. The aim of this study was to determine HBV subtypes and genotypes in HBV-infected patients in our region (southeast Brazil) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tonetto, Priscila A, Gonçales, Neiva SL, Fais, Viviane C, Vigani, Aline G, Gonçales, Eduardo SL, Feltrin, Adriana, Gonçales, Fernando L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749048/
https://www.ncbi.nlm.nih.gov/pubmed/19737394
http://dx.doi.org/10.1186/1471-2334-9-149
_version_ 1782172159796314112
author Tonetto, Priscila A
Gonçales, Neiva SL
Fais, Viviane C
Vigani, Aline G
Gonçales, Eduardo SL
Feltrin, Adriana
Gonçales, Fernando L
author_facet Tonetto, Priscila A
Gonçales, Neiva SL
Fais, Viviane C
Vigani, Aline G
Gonçales, Eduardo SL
Feltrin, Adriana
Gonçales, Fernando L
author_sort Tonetto, Priscila A
collection PubMed
description BACKGROUND: Knowledge of HBV genotype is very important for clinical treatment. Studies have suggested possible pathogenic and therapeutic differences among HBV genotypes. The aim of this study was to determine HBV subtypes and genotypes in HBV-infected patients in our region (southeast Brazil) and to correlate results with clinical and histopathological data. METHODS: One hundred and thirty-nine HBsAg-positive patients were included in the study. All patients were anti-HCV and anti-HIV negative (64% male; mean age 42 ± 14.5 years; range 7-80 years; 84% Caucasian) and were followed up at the University Hospital. A method for genotyping and subtyping HBV by partial HBsAg gene sequencing with primers common to all known genotypes was used. The viral load was measured by Amplicor Monitor assay (Roche). RESULTS: HBV genotype A was the most prevalent (55%), while genotypes C, D and F were found in 3%, 38% and 4% of HBV-infected patients, respectively. Among the patients infected by genotype A, 18.3% (14/76) were African descendents and, among the patients infected by genotype D, 11.3% (6/53) were also African descendents. In the four patients infected with genotype C, 2 were Asian descendents and 2 were Caucasians. All (7) genotype F infected patients were Caucasians. Seventy percent of our HBsAg-positive patients were HBeAg negative (62% genotypes A; 26.2% D; 7.1% C and 4.7%F). The viral load of HBV-DNA was about 5 times higher in HBeAg-positive than in HBeAg-negative patients. About 40% of these patients had alanine aminotransferase of up to 1.5 times the normal level. The mean stage of fibrosis in genotype A patients (2.8) was significantly higher than the mean stage of fibrosis in genotype D patients (2.0) (P = 0.0179). CONCLUSION: The genotypes encountered in our HBV-infected patients were apparently a consequence of the types of immigration that occurred in our region, where European and African descendents predominate. The HBeAg-negative status predominated, possibly due to the length of time of infection. The viral load in HBeAg-positive patients was higher than in HBeAg-negative individuals. The fibrosis grade in genotype A-infected patients was more advanced than genotype D-infected patients.
format Text
id pubmed-2749048
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27490482009-09-23 Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of Brazil Tonetto, Priscila A Gonçales, Neiva SL Fais, Viviane C Vigani, Aline G Gonçales, Eduardo SL Feltrin, Adriana Gonçales, Fernando L BMC Infect Dis Research Article BACKGROUND: Knowledge of HBV genotype is very important for clinical treatment. Studies have suggested possible pathogenic and therapeutic differences among HBV genotypes. The aim of this study was to determine HBV subtypes and genotypes in HBV-infected patients in our region (southeast Brazil) and to correlate results with clinical and histopathological data. METHODS: One hundred and thirty-nine HBsAg-positive patients were included in the study. All patients were anti-HCV and anti-HIV negative (64% male; mean age 42 ± 14.5 years; range 7-80 years; 84% Caucasian) and were followed up at the University Hospital. A method for genotyping and subtyping HBV by partial HBsAg gene sequencing with primers common to all known genotypes was used. The viral load was measured by Amplicor Monitor assay (Roche). RESULTS: HBV genotype A was the most prevalent (55%), while genotypes C, D and F were found in 3%, 38% and 4% of HBV-infected patients, respectively. Among the patients infected by genotype A, 18.3% (14/76) were African descendents and, among the patients infected by genotype D, 11.3% (6/53) were also African descendents. In the four patients infected with genotype C, 2 were Asian descendents and 2 were Caucasians. All (7) genotype F infected patients were Caucasians. Seventy percent of our HBsAg-positive patients were HBeAg negative (62% genotypes A; 26.2% D; 7.1% C and 4.7%F). The viral load of HBV-DNA was about 5 times higher in HBeAg-positive than in HBeAg-negative patients. About 40% of these patients had alanine aminotransferase of up to 1.5 times the normal level. The mean stage of fibrosis in genotype A patients (2.8) was significantly higher than the mean stage of fibrosis in genotype D patients (2.0) (P = 0.0179). CONCLUSION: The genotypes encountered in our HBV-infected patients were apparently a consequence of the types of immigration that occurred in our region, where European and African descendents predominate. The HBeAg-negative status predominated, possibly due to the length of time of infection. The viral load in HBeAg-positive patients was higher than in HBeAg-negative individuals. The fibrosis grade in genotype A-infected patients was more advanced than genotype D-infected patients. BioMed Central 2009-09-08 /pmc/articles/PMC2749048/ /pubmed/19737394 http://dx.doi.org/10.1186/1471-2334-9-149 Text en Copyright ©2009 Tonetto et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Tonetto, Priscila A
Gonçales, Neiva SL
Fais, Viviane C
Vigani, Aline G
Gonçales, Eduardo SL
Feltrin, Adriana
Gonçales, Fernando L
Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of Brazil
title Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of Brazil
title_full Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of Brazil
title_fullStr Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of Brazil
title_full_unstemmed Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of Brazil
title_short Hepatitis B virus: molecular genotypes and HBeAg serological status among HBV-infected patients in the southeast of Brazil
title_sort hepatitis b virus: molecular genotypes and hbeag serological status among hbv-infected patients in the southeast of brazil
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749048/
https://www.ncbi.nlm.nih.gov/pubmed/19737394
http://dx.doi.org/10.1186/1471-2334-9-149
work_keys_str_mv AT tonettopriscilaa hepatitisbvirusmoleculargenotypesandhbeagserologicalstatusamonghbvinfectedpatientsinthesoutheastofbrazil
AT goncalesneivasl hepatitisbvirusmoleculargenotypesandhbeagserologicalstatusamonghbvinfectedpatientsinthesoutheastofbrazil
AT faisvivianec hepatitisbvirusmoleculargenotypesandhbeagserologicalstatusamonghbvinfectedpatientsinthesoutheastofbrazil
AT viganialineg hepatitisbvirusmoleculargenotypesandhbeagserologicalstatusamonghbvinfectedpatientsinthesoutheastofbrazil
AT goncaleseduardosl hepatitisbvirusmoleculargenotypesandhbeagserologicalstatusamonghbvinfectedpatientsinthesoutheastofbrazil
AT feltrinadriana hepatitisbvirusmoleculargenotypesandhbeagserologicalstatusamonghbvinfectedpatientsinthesoutheastofbrazil
AT goncalesfernandol hepatitisbvirusmoleculargenotypesandhbeagserologicalstatusamonghbvinfectedpatientsinthesoutheastofbrazil